Clinical Trials
3 trialsNCT05150353 2026-06-04
AMYLOCARP
Ramsay Générale de Santé
Phase NA Completed
NCT05184088 2026-06-02
CArdiag
Lantheus Biosciences Ltd.
Phase 3 Completed
NCT07585331 2026-05-13
Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance
Fondazione IRCCS Policlinico San Matteo di Pavia
Completed